Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$4.02 - $8.23 $10,970 - $22,459
-2,729 Reduced 0.65%
415,758 $1.76 Million
Q4 2021

Feb 14, 2022

BUY
$6.99 - $9.39 $474,306 - $637,158
67,855 Added 19.35%
418,487 $3.22 Million
Q3 2021

Nov 12, 2021

BUY
$7.73 - $10.65 $2.71 Million - $3.73 Million
350,632 New
350,632 $3.17 Million

About Renovacor, Inc.


  • Ticker RCOR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,267,700
  • Description
  • Renovacor, Inc., a biotechnology company, focuses on delivering various precision therapies to enhance the lives of patients and families battling genetically-driven cardiovascular and mechanistically-related diseases. It primarily focuses on the treatment of BCL2-associated athanogene 3 (BAG3) mutation-associated dilated cardiomyopathy (DCM). T...
More about RCOR
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.